Should the Currently Recommended Twice-Daily Dosing Still be Considered the Most Appropriate Regimen for Treating MRSA Ventilator-Associated Pneumonia with Vancomycin?

Author： Pea Federico  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.47, Iss.3, 2008-01, pp. : 147-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What Is the Best Strategy for Converting from Twice-Daily Divalproex to a Once-Daily Divalproex ER Regimen?: Examinations and Answers via Computer Simulations

By Ronald C. Reed   Sandeep Dutta  

Clinical Drug Investigation, Vol. 24, Iss. 9, 2004-01 ,pp. : 509-521

Adis International

Access to resources Recommend Favorite

Ventilator-associated pneumonia: an overview

By DiCocco Jennifer M   Croce Martin A  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1461-1467

Informa Healthcare

Access to resources Recommend Favorite

Once- Versus Twice-Daily Tacrolimus: Are the Formulations Truly Equivalent?

By Barraclough Katherine A.  

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1561-1577

Adis International

Access to resources Recommend Favorite

Lithium for Older Adults with Bipolar Disorder: Should it Still be Considered a First-Line Agent?

By Shulman Kenneth I.  

Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. : 607-615

Adis International

Access to resources Recommend Favorite

Resolution of Chest X-Ray Opacities in Patients with Ventilator-associated Pneumonia

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 18, Iss. 1, 2018-03 ,pp. : 23-28

Bentham Science Publishers

Access to resources Recommend Favorite